AzTrials
AzTrials

Quadratus Lumborum BlockQLBNCT04670224

Efficiency of the Quadratus Lumborum Block for Post-operative Analgesia in Abdominoplasty Surgery

A study testing QLB anesthesia and Intravenous anesthesia without QLB in people with Quadratus Lumborum Block and Abdominoplasty, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Abdominoplasty is a common surgical procedure in plastic surgery which causes postoperative pain and may delay patients' recovery. Surgery is potentially associated with a number of postoperative complications, whether cardiovascular, respiratory, infectious, thromboembolic, or digestive … Although they do not… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
QLB anesthesia and Intravenous anesthesia without QLB
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
286 participants
Where
1 siteFrance
Study dates
16 Mar 2021to Jan 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients admitted for programmed dermo-lipectomy surgery with or without associated liposuction.

Who cannot join

  • Pregnant woman
  • Patient under 18 years of age
  • Subject under guardianship or curators
  • Patient allergic to local anesthetics
  • Infection at the puncture sites
  • Patient on morphine analgesic over the long term
  • Patient on antidepressants for neuropathic pain.

Trial locations and contacts

1 site in 1 country.

France1 site
  • BAR

    Amiens, 80054

Other trials in France

About this study

Abdominoplasty is a common surgical procedure in plastic surgery which causes postoperative pain and may delay patients' recovery. Surgery is potentially associated with a number of postoperative complications, whether cardiovascular, respiratory, infectious, thromboembolic, or digestive … Although they do not inevitably lead to a life-threatening prognosis, in many cases these complications delay post-operative recovery. Defined in the 1990s by Professor Henry Kehlet's Danish team, rapid rehabilitation after planned surgery is an approach to overall patient care that aims to rapidly restore previous physical and mental capacities and thus significantly reduce mortality and morbidity. Pain management is at the heart of this program and local anesthesia techniques are at the heart of early rehabilitation programs.

Described for just over a decade, Quadratus Lumborum Block (QLB) have shown their effectiveness for analgesia in abdominal, or orthopedic, or obstetrical surgery. Considering the anatomical territory concerned, this locoregional anesthesia technique seems to be very interesting in abdominoplasty to allow early rehabilitation of the patient.

Being tested
QLB anesthesia, Intravenous anesthesia without QLB
Keywords
Quadratus lumborum block, Abdominoplasty, Analgesia, Locoregional Anesthesia
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QLB anesthesiaOther

    The QLB is a bilateral locoregional anesthesia technique, performed after surgery, under general anesthesia and in right and then left lateral decubitus.

  • Intravenous anesthesia without QLBOther

    only intravenous anesthesia

Study groups in NCT04670224
Study groupRoleWhat they receive
QLB techniqueExperimentalNot described
Receives: Other: QLB anesthesia
Intravenous anesthesia without QLBActive comparatorNot described
Receives: Other: Intravenous anesthesia without QLB

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Variation from baseline of morphine consumption

    Measured: 24 hours after surgery

Secondary outcomes (3)
  1. Variation from baseline of morphine consumption

    Measured: 1 hour after surgery

  2. Variation from baseline of morphine consumption

    Measured: 2 hours after surgery

  3. Variation from baseline of morphine consumption

    Measured: 48 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2020
  2. Study start16 Mar 2021
  3. Primary completionDec 2025 (estimated)
  4. Study completionJan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
286 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04670224
Sponsor's protocol ID
PI2020_843_0094
Acronym
QLB
Status last verified
May 2025
First submitted
1 Dec 2020
Last updated
29 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing QLB anesthesia and Intravenous anesthesia without QLB in people with Quadratus Lumborum Block and Abdominoplasty, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 29 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Variation from baseline of morphine consumption (time frame: 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in